VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
WVEWave Life Sciences Ltd.$5.81$1.1B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksWVEEarnings History

WVE logoWave Life Sciences Ltd. (WVE) Earnings History

Net Loss

13 years of earnings data (2013–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$184M
● Net Loss
TTM EPS (Diluted)
$-0.92
Per share, diluted
YoY EPS Growth
-72.9%
Declining
Net Margin
-478.3%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-504.1%
Gross Margin79.3%
Return on Equity-55.6%
Return on Assets-41.3%
Record Annual Net Income-$3MFY2013
Record Quarterly EPS$0.17Q4 2024
Consecutive Profitable Years0years
Q1 2026
Net Income-$26M
EPS (Diluted)$-0.13
YoY Growth-72.9%Declining
QoQ Growth+50.9%Excellent

Loading earnings history...

Wave Life Sciences Ltd. (WVE) Earnings Overview

As of June 12, 2026, Wave Life Sciences Ltd. (WVE) reported trailing twelve-month net income of -$184M, reflecting -72.9% year-over-year growth. The company earned $-0.92 per diluted share over the past four quarters, with a net profit margin of -478.3%.

Looking at the long-term picture, WVE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3M in fiscal 2013.

Wave Life Sciences Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including SRPT ($65M net income, -32.5% margin), IONS (-$327M net income, -40.4% margin), ARWR (-$301M net income, -0.2% margin), WVE has room to improve margins relative to the peer group. Compare WVE vs SRPT →

WVE Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
WVE logoWVECurrent
-$184M$-0.92-478.3%-55.6%-72.9%—
SRPT logoSRPT
$65M$0.53-32.5%-53.5%-404.7%
IONS logoIONS
-$327M$-1.98-40.4%-70.7%+21.7%
ARWR logoARWR
-$301M$-2.11-0.2%-0.5%+99.8%
NTLA logoNTLA
-$395M$-3.33-609.9%-53.5%+27.4%
BEAM logoBEAM
-$65M$-0.63-57.2%-8.1%+82.3%
Best in group
Lowest in group

WVE Historical Earnings Data (2013–2025)

13 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$204M-110.7%-$215M$-1.21-478.3%-504.1%
2024-$97M-68.7%-$110M$-0.70-89.6%-101.9%
2023-$58M+64.5%-$68M$-0.54-50.8%-60.0%
2022-$162M-32.4%-$163M$-2.05-4434.7%-4459.3%
2021-$122M+18.5%-$127M$-2.36-298.4%-310.1%
2020-$150M+22.6%-$153M$-3.82-746.7%-763.9%
2019-$194M-32.0%-$208M$-5.30-1211.5%-1303.4%
2018-$147M-43.7%-$160M$-5.06-1017.4%-1106.7%
2017-$102M-84.2%-$103M$-3.85-2754.7%-2769.4%
2016-$55M-188.5%-$55M$-2.43-3730.7%-3725.7%
2015-$19M-267.2%-$19M$-0.89-12631.6%-12696.1%
2014-$5M-57.6%-$5M$-0.25--
2013-$3M--$4M$-0.93--

Download Data

Export WVE earnings history in CSV or JSON format

Free sign-in required to download data

What if you invested $1,000 in WVE back in 2013?

Total return with dividends reinvested · 13+ years of data

Calculate Returns

How much would $100/month in WVE be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is WVE Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

WVE vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

WVE — Frequently Asked Questions

Quick answers to the most common questions about buying WVE stock.

What is WVE earnings per share (EPS)?

WVE trailing twelve-month (TTM) diluted EPS is $-0.92, reflecting -72.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2013 to 2025 is available in the table on this page.

What is Wave Life Sciences Ltd.'s net income?

Wave Life Sciences Ltd. (WVE) trailing twelve-month net income is $-184M as of 2025. Earnings declined -72.9% year-over-year.

Is WVE profitable?

WVE is not currently profitable on a TTM basis, reporting a net loss of $-184M. Net margin is -478.3%. Investors should monitor for a return to profitability.

What is WVE's earnings growth rate?

WVE compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2025.

What are WVE's profit margins?

Wave Life Sciences Ltd. net profit margin is -478.3%, operating margin is -504.1%, and gross margin is +79.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -55.6%.

Is WVE growing earnings?

WVE earnings are declining — EPS fell -72.9% year-over-year. TTM net income dropped to $-184M. This contrasts with the 5-year CAGR of N/A.

What was WVE's best earnings year?

Wave Life Sciences Ltd.'s highest annual net income on record is $-3M, achieved in fiscal year 2013. Earnings history on this page spans 2013 to 2025 and includes all annual and quarterly figures.

What were WVE's earnings last quarter?

WVE's most recent reported quarter was Q1 2026. Net income was $-26M with diluted EPS of $-0.13. For a full breakdown of all quarters, see the quarterly earnings table on this page.

WVE Earnings Over Time (2013–2025)

Net income & EPS — annual and quarterly view